Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Life360, Inc. (LIF) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as a Nasdaq-listed issuer. Life360 is a family connection and safety company that reports its financial and operational performance through filings with the U.S. Securities and Exchange Commission, including current reports on Form 8-K and other periodic reports.
In its SEC filings, Life360 presents details on subscription revenue, hardware revenue, and other revenue, which includes data and partnership revenue such as advertising. The company also discloses key performance indicators for its core mobile application, including Monthly Active Users (MAUs), Paying Circles, and Average Revenue Per Paying Circle. These metrics help investors understand the scale and engagement of Life360’s user base and the contribution of its core app to overall results.
Filings may also discuss gross margin, operating expenses, and Adjusted EBITDA, along with narrative explanations of changes in research and development, sales and marketing, and general and administrative costs. Life360 uses non-GAAP measures such as Adjusted EBITDA and core subscription revenue to supplement its GAAP results, and reconciliations are typically included in its financial disclosures.
Corporate actions and material events are reported through Forms such as Form 8-K. For example, an 8-K filed in November 2025 describes Life360’s announcement of financial results and its entry into an Agreement and Plan of Reorganization to acquire Nativo, Inc., an advertising technology company, in a transaction valued at approximately $120 million in cash and stock, subject to customary closing conditions. Such filings outline the structure of significant transactions, key terms, and the expected impact on the company.
On this page, Stock Titan surfaces Life360’s SEC filings as they are made available on EDGAR and enhances them with AI-powered summaries. These summaries are intended to highlight the main points of lengthy documents, such as earnings releases, transaction announcements, and presentations furnished as exhibits, so readers can quickly grasp the context before reviewing the full text. Users can review current reports like Form 8-K for material events, and refer to Life360’s broader set of filings for a more complete view of its financial condition, risk factors, and governance practices.
For investors tracking LIF, the filings page is a central resource to monitor how Life360 describes its business performance, revenue mix, user metrics, and strategic transactions in its own words, directly from its official submissions to the SEC.
Life360 director Chris Hulls received a grant of 26,499 restricted stock units (RSUs) that vest monthly over four years. Each RSU converts into one share upon settlement and 1/48th vests monthly beginning 09/01/2025, subject to continuous service. After the grant the reporting person beneficially owns 483,830 shares (including previously granted RSUs).
The filing discloses 151,934 previously granted RSUs, ownership through three family irrevocable trusts and a minority interest in ICCA Labs, LLC, and that 585,938 CDIs remain subject to a lock-up agreement.
Life360, Inc. (LIF) director Mark Goines received a grant of 189 Restricted Stock Units (RSUs) on 09/01/2025. Each RSU vests into one share on settlement; one-third vests on November 15, 2025, and the remaining two-thirds vest in equal quarterly installments thereafter, subject to continuous service. The reported RSUs were granted at a $0 price. After the reported transaction, the filing shows 6,070 shares beneficially owned directly and 71,809 shares held indirectly by the Goines Wong Living Trust. The filing also notes 3,055 previously granted RSUs included in the totals.
Life360, Inc. (LIF) Form 4: This filing reports insider transactions by John Burke Russell, identified as the companys Chief Financial Officer. On 08/26/2025 the reporting person sold 16,287 shares of common stock at a weighted-average price of $90.42 per share (individual trade prices ranged from $90.07 to $90.72). After the sale, the filing shows 63,030 shares beneficially owned indirectly, held by the Russell John Burke Revocable Trust. The filing also notes a prior transfer of 79,317 directly held shares to that trust, which the filer states was exempt from Section 16 under Rule 16a-13. Additionally, 111,231 restricted stock units remain recorded as contingent rights to receive common stock upon vesting. The form is signed by Allison Chang, Attorney-in-Fact, dated 08/28/2025.
Life360 insider sale by CEO/director Lauren Antonoff. The filing shows Ms. Antonoff sold 4,546 shares of Life360 common stock on 08/25/2025 at $90 per share under a pre-established Rule 10b5-1 trading plan adopted 11/27/2024. After the sale, she beneficially owns 303,232 shares, which includes 205,974 restricted stock units that convert to common shares upon vesting. The Form 4 was signed by an attorney-in-fact on 08/27/2025. The filing states the 10b5-1 plan was adopted when the reporting person was unaware of any material nonpublic information.
Mark Goines, a director of Life360, Inc. (LIF), sold 20,000 shares of the company's common stock on 08/22/2025 at a weighted average price of $86.87 per share (sales ranged $86.87–$86.93). After the sale and related transfers, the reporting person beneficially owns 71,809 shares, held indirectly through the Goines Wong Living Trust. The filing discloses that 55,537 directly held shares were transferred to that trust in a transaction exempt under Rule 16a-13, and that 2,866 restricted stock units remain contingent rights to receive shares upon vesting.
Life360, Inc. (LIF) Form 4 shows Russell John Burke, the company's Chief Financial Officer and a Director, reported a transaction dated 08/22/2025. The filing discloses a gift of 5,870 shares of common stock to a donor-advised fund; the shares were donated (code G(1)) at a price of $0 and the reporting person "retains no beneficial ownership or control" of the donated securities after the contribution.
The reporting person is shown as beneficially owning 190,548 shares following the transaction, which the filing notes includes 111,231 restricted stock units that convert to shares upon vesting. The form was signed by an attorney-in-fact on 08/26/2025.
Form 144 filed for Life360, Inc. (LIF): The filing notifies a proposed sale of 16,287 shares of common stock to be executed through Charles Schwab on 08/26/2025 on NASDAQ with an aggregate market value of $1,477,556.00. The seller previously acquired shares via equity awards on 08/19/2024 (11,100 shares), 03/27/2025 (1,541 shares), and 06/05/2025 (3,646 shares), all listed as equity compensation from the issuer. The filing also reports four completed sales by Russell John Burke in the past three months totaling 12,342 shares for gross proceeds of $820,333.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Life360, Inc. (LIF) Form 144 notice reports a proposed sale of 1,858 common shares through Fidelity Brokerage Services, with an aggregate market value of $167,220, scheduled approximately for 08/26/2025. The shares were acquired on 12/02/2024 upon restricted stock vesting and were granted as compensation. The filing lists multiple sales by the same person, Susan Stick, during the prior three months totaling 10,210 shares and gross proceeds of approximately $764,008.87 across dates from 05/27/2025 to 08/25/2025. The issuer has 77,548,651 shares outstanding per the form. The filer certifies no undisclosed material adverse information and attests to the truthfulness of the notice.
Life360, Inc. (LIF) filed a Form 144 reporting proposed sale of common stock by an insider. The notice lists 3,323 shares planned for sale through Fidelity Brokerage Services with an aggregate market value of $299,563.47, and an approximate sale date of 08/25/2025 on NASDAQ. The filing shows those shares were acquired in 2024 through restricted stock vesting as compensation (622 shares on 09/19/2024, 969 shares on 11/15/2024, and 1,732 shares on 12/02/2024). The filing also discloses historical sales by the same person, Susan Stick, totaling 6,387 shares sold across seven transactions in 2025, generating $419,445.40 in gross proceeds.
Life360, Inc. insider Lauren Antonoff filed a Form 144 to sell 4,546 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $409,140, and an intended sale date of 08/25/2025. The shares were acquired on 06/20/2024 via restricted stock vesting and were received as compensation. The filing reports total outstanding shares of 77,548,651. The notice also discloses four prior sales by the same person in the past three months totaling 32,446 shares for gross proceeds of $2,125,940.60.
FAQ
What is the current stock price of Life360 (LIF)?
What is the market cap of Life360 (LIF)?
